Cocrystal Pharma (COCP) EBIT Margin (2010 - 2026)
Cocrystal Pharma (COCP) posted EBIT Margin of 1047.11% for Q1 2026, down 264.27% sequentially from 287.45% in Q4 2020.
Cocrystal Pharma (COCP) EBIT Margin (2010 - 2026) Analysis & Trends
Cocrystal Pharma has reported EBIT Margin for 8 years, with the latest figure at 1047.11% in Q1 2026.
- Quarterly EBIT Margin changed N/A year-over-year to 1047.11% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 508.1% (changed N/A YoY) and the FY2020 annual result came in at 475.97%, up 26148.0% from the prior year.
- EBIT Margin declined to 1047.11% in Q1 2026 per COCP's latest filing, from 287.45% in the prior quarter.
- Over five years, EBIT Margin peaked at 1047.11% in Q1 2026 and troughed at 1047.11% in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 37.40% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 30.15% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 32.54% |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -562.07% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 19.06% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 17.93% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -35.57% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.36% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 19.75% |
| 10 | Cocrystal Pharma | 15.65 Mn | 13.33 Mn | - | -3,032.38% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3,032.38% |
| Mar 31, 2026 | -1,047.11% |
| Dec 31, 2020 | -287.45% |
| Sep 30, 2020 | -553.99% |
| Jun 30, 2020 | -622.74% |
| Mar 31, 2020 | -425.38% |
| Dec 31, 2019 | -11,921.64% |
| Sep 30, 2019 | -367.48% |
| Jun 30, 2019 | -261.82% |
| Mar 31, 2019 | 56.66% |
| Sep 30, 2015 | -14,958.33% |
| Jun 30, 2015 | -14,137.04% |
| Mar 31, 2015 | -8,029.63% |
| Jun 30, 2013 | -37.85% |
| Mar 31, 2013 | -50.27% |
| Dec 31, 2012 | -64.08% |
| Sep 30, 2012 | 6.92% |
| Jun 30, 2012 | 5.35% |
| Mar 31, 2012 | -16.85% |
| Dec 31, 2011 | -21.30% |